Literature DB >> 16031880

Route of BCG administration in possums affects protection against bovine tuberculosis.

F E Aldwell1, D L Keen, V C Stent, A Thomson, G F Yates, G W de Lisle, B M Buddle.   

Abstract

The Australian brushtail possum (Trichosurus vulpecula) is the major wildlife reservoir of Mycobacterium bovis in New Zealand. Control of bovine tuberculosis in farmed animals requires measures to reduce the transmission of M. bovis from wildlife. Possums were vaccinated with BCG intranasally by aerosol spray, orally or subcutaneously to compare the efficacy of these three routes on protection against challenge with virulent M. bovis. Possums vaccinated with BCG by the intranasal or subcutaneous routes had a marked reduction in severity of disease compared to possums which had been unvaccinated or orally vaccinated. The severity of the disease was assessed by changes in body weight and pathology. BCG vaccination by all three routes resulted in reduced dissemination of M. bovis to the spleen and liver following challenge. Intranasal and oral BCG vaccination induced lower mean peripheral blood lymphocyte blastogenic responses to bovine PPD than subcutaneous vaccination, indicating that these responses did not correlate well with protection from the disease. Given a suitable delivery system, aerosol vaccination of possums, used in conjunction with other control measures, may be a suitable method of reducing the spread of M. bovis from wildlife to domestic animals.

Entities:  

Year:  1995        PMID: 16031880     DOI: 10.1080/00480169./1995.35920

Source DB:  PubMed          Journal:  N Z Vet J        ISSN: 0048-0169            Impact factor:   1.628


  6 in total

Review 1.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

2.  Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice.

Authors:  Frank E Aldwell; Ian G Tucker; Geoffrey W de Lisle; Bryce M Buddle
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

3.  Oral vaccination of guinea pigs with a Mycobacterium bovis bacillus Calmette-Guerin vaccine in a lipid matrix protects against aerosol infection with virulent M. bovis.

Authors:  Simon Clark; Martin L Cross; Allan Nadian; Julia Vipond; Pinar Court; Ann Williams; R Glyn Hewinson; Frank E Aldwell; Mark A Chambers
Journal:  Infect Immun       Date:  2008-06-02       Impact factor: 3.441

4.  Mycobacterium bovis: A Model Pathogen at the Interface of Livestock, Wildlife, and Humans.

Authors:  Mitchell V Palmer; Tyler C Thacker; W Ray Waters; Christian Gortázar; Leigh A L Corner
Journal:  Vet Med Int       Date:  2012-06-10

Review 5.  Efficacy and Safety of BCG Vaccine for Control of Tuberculosis in Domestic Livestock and Wildlife.

Authors:  Bryce M Buddle; Hans Martin Vordermeier; Mark A Chambers; Lin-Mari de Klerk-Lorist
Journal:  Front Vet Sci       Date:  2018-10-26

6.  Roles of Mucosal Immunity against Mycobacterium tuberculosis Infection.

Authors:  Wu Li; Guangcun Deng; Min Li; Xiaoming Liu; Yujiong Wang
Journal:  Tuberc Res Treat       Date:  2012-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.